Skip to content

Acute Effect of Nurse-assessed Remote Ischemic Preconditioning on Improving Vascular Parameters in Patients With Suspected Heart Failure With Preserved Ejection Fraction

Acute Effect of Nurse-assessed Remote Ischemic Preconditioning on Improving Vascular Parameters in Patients With Suspected Heart Failure With Preserved Ejection Fraction

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07365501
Acronym
PIRIC-FEp
Enrollment
48
Registered
2026-01-26
Start date
2025-10-01
Completion date
2027-02-28
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HF - Heart Failure

Brief summary

The PIRIC-FEp study will be a randomized clinical trial in sedentary patients with suspected heart failure with preserved ejection fraction. Objectives: 1) To evaluate the acute efficacy of remote ischemic preconditioning performed by nurses, a noninvasive cardioprotective intervention that uses cycles of ischemia and reperfusion in the extremities, in improving vascular parameters. Methodology: Patients will be recruited in Health Centers in the city. Those assigned to the intervention group will wear a self-administered blood pressure cuff, inflated to 220 mmHg for 5 minutes, followed by 5 minutes of deflation, in repeated cycles four times. The control group will receive no intervention. All participants will be examined, at baseline, 0 minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post intervention. Different vascular parameters will be evaluated, including peripheral and central Systolic and Blood Pressure, peripheral and central Mean Arterial Pressure, peripheral and central Pulse Pressure, Heart Rate, Cardiac Output, Stroke Volume, Peripheral Vascular Resistance, aortic Pulse Wave Velocity and Augmentation Index normalized to a heart rate of 75 beats per minute. The study will be approved by an Ethics Committee, participants will be informed and will have to sign a written consent. The statistical analysis will include three phases: verification of randomization, use of covariance models for dependent variables, and sensitivity analysis with propensity score matching. All analyses will be performed on an intention-to-treat basis.

Interventions

PROCEDUREremote ischemic preconditioning

Participants randomized to the remote ischemic preconditioning intervention group will receive a hand-held blood pressure device (Welch Allyn DuraShock™ DS45, NY, USA) to self-administer remote ischemic preconditioning. The cuff will be placed around the upper arm and inflated to 220 mmHg for 5 minutes, followed by 5 minutes of deflation, and this cycle will be repeated another three times. The arm on which participants will apply the PIR is the left arm. Participants will be supervised during the PIR session by a nurse to ensure that it is performed correctly.

Sponsors

University of Castilla-La Mancha
Lead SponsorOTHER
Universidad Pontificia Comillas
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Signs and symptoms of Heart Failure (Clinical suspicion of Heart Failure) 2. Sedentary men and women (structured exercise \<2 x 30 min/week). 3. Age ≥40 years 4. Written informed consent 5. Clinically stable for 6 weeks 6. Optimal medical treatment for ≥6 weeks.

Exclusion criteria

1. Non-cardiac causes of Heart Failure symptoms: * Significant valvular or coronary artery disease * Uncontrolled hypertension or arrhythmias * Primary cardiomyopathies 2. Significant pulmonary disease (FEV1\<50% predicted, GOLD III-IV) 3. Inability to exercise or conditions that may interfere with exercise intervention. 4. Myocardial infarction within the last 3 months. 5. Patients with diabetes and/or peripheral vascular disease. 6. Comorbidity that may influence prognosis at one year. 7. Participation in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionhe maximum arterial pressure during ventricular systole, measured at the brachial artery by the Mobil-O-Graph using oscillometric technology.
Diastolic Blood PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe minimum arterial pressure during ventricular diastole, measured at the brachial artery by the Mobil-O-Graph using oscillometric technology.
Pulse PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe difference between systolic and diastolic brachial blood pressure, calculated by the Mobil-O-Graph and reflecting the pulsatile component of arterial load.
Heart RateBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe number of heart beats per minute, determined by the Mobil-O-Graph from the time interval between consecutive oscillometric pulse waves.
Central Systolic Blood PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe estimated systolic pressure in the ascending aorta, derived by the Mobil-O-Graph through reconstruction of the central pulse wave from the brachial oscillometric signal.
Central Diastolic Blood PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe estimated diastolic pressure at the central (aortic) level, calculated by the Mobil-O-Graph using pulse wave analysis algorithms.
Central Pulse PressureBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe difference between estimated central systolic and diastolic blood pressure, calculated by the Mobil-O-Graph to represent aortic pulsatile pressure.
Cardiac OutputBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe volume of blood pumped by the heart per minute, estimated by the Mobil-O-Graph from stroke volume calculations combined with heart rate.
Stroke VolumeBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe volume of blood ejected by the left ventricle per heartbeat, estimated by the Mobil-O-Graph using hemodynamic modeling based on pulse wave analysis.
Peripheral Vascular ResistanceBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionhe resistance of the peripheral circulation to blood flow, estimated by the Mobil-O-Graph from calculated mean arterial pressure and cardiac output.
Pulse Wave VelocityBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionThe speed at which the arterial pulse wave propagates through the arterial tree, estimated by the Mobil-O-Graph as an indirect marker of arterial stiffness.
Augmentation Index normalized to 75 bpmBaseline, 0 Minutes post intervention, 30 minutes post intervention, 60 minutes post intervention and 24 hours post interventionAn index quantifying the contribution of reflected pressure waves to central arterial pressure, estimated by the Mobil-O-Graph from the reconstructed central pulse wave and normalized to a heart rate of 75 beats per minute.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026